Literature DB >> 32492469

Efficacy and safety of very-low-dose oral minoxidil 1.25 mg in male androgenetic alopecia.

Abhijeet Kumar Jha1, Sidharth Sonthalia2, M D Zeeshan1, Keshavamurthy Vinay3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32492469     DOI： 10.1016/j.jaad.2020.05.129

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

1.  Oral minoxidil use in androgenetic alopecia and telogen effluvium.

Authors:  Brittany Feaster; Toluwalashe Onamusi; Jerry E Cooley; Amy J McMichael
Journal:  Arch Dermatol Res       Date:  2022-03-04       Impact factor: 3.017

2.  There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses.

Authors:  Aditya K Gupta; Deanna C Hall; Mesbah Talukder; Mary A Bamimore
Journal:  Skin Appendage Disord       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.